Dialysis Drugs(tesis drugs)

8/20/2019 Dialysis Drugs(tesis drugs)

1/22

NAME

OF

DRUG

MECHANIS

M OF

ACTION

CLASSIFICA

TION

DOSAGE INDICATION CONTRAIND

ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY

BRAND

NAME:Ferrogr

ad fol!

GENERI

C

NAME:

Ferro"#

S"lfa$e

% Fol!

a!d

Ferro"##"l&'a$e I$(or)#*+re&la!,g ro,, +o"r*od+ f +o"r

*od+doe#,o$&rod"!ee,o"g'o, $#o(,

Fol!

a!d'el+o"r*od+&rod"!e a,d.a,$a, ,e(!ell#/

A,$a,e

.!

011

.g 211

.gO,e

$a*

&er

da+

Trea$,g

a,e.a

!a"#ed

*+ lo(

le3el# of

ro, or

fola$e ,

$'e

*lood I$

re&la!e#

ro, ,

$'e *od+

('e, $'e

*od+

doe# ,o$

&rod"!e

e,o"g'

o, $#o(,

Co,$ra,

d!a$ed

,

&a$e,$#

('o

'a3e

e4&ere,

!ed ($'

&aro4+#

.al,o!$"r,a

l

'e.oglo

*,"ra

5'e.ogl

o*, ,

$'e

"r,e/

e#&e!all+

o*#er3e

d , $'e

.or,,g

a# dar)

!olored

"r,e6/

GI:

d#!o.f

or$/

'ear$

*"r,/

lo## of

a&&e$$e

/

,a"#ea/

3o.$,g/

!o,#$&a

$o,/

darr'ea

S$ool

dar)e,

,g or

*lood+

#$ool.a+

o!!"r

Ad3#e &a$e,$

$o $a)e ferro"#

f".ara$e7fol!

a!d ($' a f"ll

gla## of (a$er

Do ,o$ le do(,

for 81 .,"$e#

af$er $a),g

ferro"#

f".ara$e7fol!a!d

Ta)e ferro"#

f".ara$e a,d

fol! a!d o, a,

e.&$+

#$o.a!'/ a$

lea#$ 9 'o"r

*efore or 0'o"r# af$er a

.eal

If +o" .## a

do#e of ferro"#

f".ara$e7fol!

a!d/ $a)e $ a#


2/22

a,dal#o'el

&re3e,$!'a,ge# $oDNA$'a$.a+lead $o!a,!er

a!!"."l

a$o, of

ro,/ a,d

e4!e##

ro, ,

$'e *od+

#oo, a#

&o##*le If $ #

al.o#$ $.e for

+o"r ,e4$ do#e/

#)& $'e .##ed

do#e a,d go

*a!) $o +o"r

reg"lar do#,g

#!'ed"le Do

,o$ $a)e 0

do#e# a$ o,!e

Tell $'e &a$e,$

$'a$ Ferro"#f".ara$e7fol!

a!d .a+ !a"#e

dar)e,ed or

gree, #$ool#

T'# # ,or.al

a,d ,o$ a !a"#e

for !o,!er,

Do NOT $a)e.ore $'a, $'e

re!o..e,ded

do#e ($'o"$

!'e!),g ($'

+o"r do!$or


3/22


4/22

NAME

OF

DRUG

MECHANIS

M OF

ACTION

CLASSIFIC

A -TION


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY

BRAND

NAME:.o$ll"

.

GENERI

C

NAME:

Do.&er

do,e

Do.&er

do,e a!$#a# a

ga#$ro,$

e#$,al

e.&$+,g

5dela+ed6

ad",!$

a,d

&er#$al$

!#$."la,$

Do.&er

do,e

fa!l$a$e#

ga#$r!

e.&$+,g

a,d

de!rea#e

# #.all*o(el

$ra,#$

$.e *+

,!rea#,

g

e#o&'age

al a,d

A,$do

&a.,e

rg! A,$e.

e$!

91 "g

o,e

$a* 8

$.e#

a da+

For

.a,age

.e,$ of

d+#&e

a/

'ear$*"r,

/

e&ga#$r!

&a,/

,a"#ea/a,d

3o.$,g

Co,$ra,

d!a$ed

,

&a$e,$#

($'

),o(,

#e,#$3$

+

or ,$oler

a,!e $o$'e dr"g

ra#'

I$!',g 'eada!'

e dr+

.o"$' d;;,e#

# ,er3o"#

,e##

rr$a*l$

+ leg

!ra.

A##e## for e4$ra-

&+ra.dal e


5/22

ga#$r!

&er#$al#

# a,d *+

lo(er,g

e#o&'ageal

#&',!$er

&re##"re


6/22

NAME

OF

DRUG

MECHANISM

OF ACTION

CLASSIFICATI

ONDOSAGE INDICATION CONTRAINDI

CA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY

BRAND

NAME:Co;aar

Ar*lo!

GENER

IC

NAME:

Lo#ar$

a,

Lo#ar$a,

5.ore#&e!=!all

+/ $'e

!'e.!al

for.ed

('e,

$'e l3er !

o,3er$#

$'e

,a!$3elo#ar$a,

,$o $#

a!$3e

for.6

*lo!)#

$'e

a,go$e,#

,

re!e&$or

B+*lo!),g

$'e

a!$o, of

a,go$e,#

,/

lo#ar$a,

rela4e#

A,go$e

,#, II

re!e&$or

*lo!)er

911.

g $a*

o,!e a

da+

Trea$.e

,$ of

da*e$!

,e&'ro&

a$'+ ,

$+&e 0

da*e$e#

($'

'+&er$e,

#o,

Co,$ra,d

!a$ed ,

&a$e,$

('o are

da*e$!

a,d

$a),g al

#)re,

U&&er

Re#&ra$

or+

Tra!$

I,fe!$o

, D;;,e#

# I,#o.,

a M"#!le

Cra. Leg Pa,

H+&er)a

le.a A,goed

e.a Or$'o#$

a$!

H+&o$e,

#o,

A##e##&a$e,$#

re,al f",!$o,

Ad.,#$er

($'o"$ regard

$o .eal#

Mo,$or &a$e,$#

BP

Mo,$or

&a$e,$# ('o

are al#o $a),g

d"re$!#

for #+.&$o.a$

!

'+&o$e,#o,

Tell &a$e,$ $oa3od

#al$ #"*#$$"$e

#

Mo,$or

&a$e,$ !lo#el+

, a,+


7/22

."#!le

!ell# a,d

dla$e#

*lood

3e##el#$'ere*+

red"!,g

*lood

&re##"re

#$"a$o, $'a$

.a+ lead $o a

de!rea#e ,

*lood &re##"re#e!o,dar+ $o

red"!$o, ,

>"d 3ol".e

e4!e##3e

&er#&ra$o,/

de'+dra$o,/

3o.$,g/ a,d

darr'ea

e4!e##3e

'+&o$e,#o,

!a, o!!"r

NAME

OF

DRUG

MECHANISM

OF ACTION

CLASSIFI

CA-TION


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


8/22

BRAND

NAME:

Nor3a#!

A.3a#!

BE

GENERI

C NAME:

A.lod&

,e

I,'*$#

$'e

.o3e.e,

$ of

!al!".

o,#

a!ro## $'e

.e.*ra,

e# of

!arda!

a,d

ar$eral

."#!le!ell#?

,'*$# $r

a,#.e.*

ra,e !al!

". >o(/

('!'

re#"l$# ,

$'e

de&re##o, of

.&"l#e

for.a$o,

,

#&e!al;e

d !arda!

&a!e.a)e

Cal!"

.

!'a,,

el-

*lo!)

er A,$a

,g,al

dr"g A,$'

+&er$

e,#3

e

I,$all

+/

2 .g

PO

dal+ Do#a

ge

.a+

*e

grad"

all+

,!rea

#edo3er

91@9

da+#

$o a

.a4

.".

do#e

of

91 .g PO

dal+

A,g,a

&e!$or#

d"e $o

!oro,ar+

ar$er+

#&a#. C'ro,!

#$a*le

a,g,a/

alo,e or

,

!o.*,a$

o, ($'o$'er

age,$# E##e,$al

'+&er$e,

#o,/

alo,e or

,

!o.*,a$

o, ($'o$'er a,$

'+&er$e,

#3e#

Co,$ra,

d!a$ed

($'

allerg+

$o a.lod

&,e/

.&ared

'e&a$!

or re,al

f",!$o,/

#!)

#,"#

#+,dro.e/ 'ear$

*lo!)

5#e!o,d

or $'rd

degree6/

a,d

la!$a$o,

U#e!a"$o"#l

+ ($'

CHF/

&reg,a,

!+

CNS:

D;;,e#

#/ lg'$-

'eaded

,e##/

'eada!'

e/ a#$'e

,a/ fa$

g"e/

le$'arg+

CV:

Per&'er

al

ede.a/

arr'+$'

.a

Dermat

ologic:Fl"#',g

/ ra#'

GI: Na"

#ea/ a*d

o.,al

d#!o.f

or$

Mo,$or

&a$e,$

!aref"ll+ 5BP/

a,d o"$&"$6('le

ad"#$,g

dr"g $o

$'era&e"$!

do#e

Mo,$or

!arda!

r'+$'.

reg"larl+

d"r,g

#$a*l;a$o,

of do#age

a,d

&erod!all+

d"r,g lo,g-

$er. $'era&+

Ad.,#$er

dr"g ($'o"$

regard $o

.eal# *"$

$a)e ($'

.eal# f


9/22

r !ell#/

#lo(,g of

$'e

3elo!$+ of

!o,d"!$o

, of $'e

!arda!

.&"l#e/

de&re##o

, of

.+o!arda

l

!o,$ra!$l$+/ a,d

dla$o, of

!oro,ar+

ar$ere#

a,d

ar$erole#

a,d

&er&'eral

ar$erole#?$'e#e

e


10/22

!arda!

o4+ge,

!o,#".&$

o,/ a,d ,

&a$e,$#

($' 3a#o#

&a#$! 5Pr

,;.e$al#6

a,g,a/

,!rea#ed

del3er+ of

o4+ge, $o

!arda!

!ell#

#'or$,e## of

*rea$'/

#(ell,g of

$'e 'a,d# orfee$/

d;;,e##/

a,d

!o,#$&a$o,


11/22

NAME

OF

DRUG

MECHANIS

M OF

ACTION

CLASSIFICA

TION


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY

BRAND

NAME:E&oge,

Pro!r$

GENERI

C

NAME:

E&oe$,

Alfa

M.!#

$'ee


12/22

o, Se;"re# ",der#$a,d,

g o$'er#

#&ee!'

Mo,$or f

feel# #"dde,

$ro"*le ,

(al),g/

d;;,e##/ lo##

of *ala,!e or

!oord,a$o,

Mo,$or BP

*efore $'e

$'era&+

NAME

OF

DRUG

MECHANIS

M OF

ACTION

CLASSIFICA

TION


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


13/22

BRAND

NAME:

Ne4".

GENERI

C

NAME:

E#o.e&

ra;ole

Red"!e

#

ga#$r!

a!d

#e!re$

o, a,d

de!rea

#e#

ga#$r!

a!d$+

Pro$o,

P".&

I,'*$or

#

1g

o1,e

!a&

o,!e a

da+

Ga#$roe#

o&'ageal

re>"4

d#ea#e

5GERD6 To red"!e

r#) of

ga#$r!

"l!er ,

&a$e,$#

re!e3,g

!o,$,"o

"#

NSAIDS

$'era&+ To

el.,a$e

H &+lor

Co,$ra,

d!a$ed

,

&a$e,$

($'

'e&a$!

,#"!e

,!+ a,d

,

&reg,a,$

a,d

la!$a$,g

.o$'er

CNS:

'eada!'

e

GI:

A*do.,al &a,/

!o,#$&a

$o,/

darr'ea

/ dr+

.o"$'/

>a$"le,

!e/

,a"#ea/

3o.$,

g

G3e dr"g a$

lea#$ 9 'o"r

*efore .eal#

If 3a NGT

o&e, !a"le

a,d e.&$+ $'e

gra,"le# ,$o a

1 .l #+r,ge

Mo,$or

&a$e,$# for

ra#' or #g,#

a,d #+.&$o.#

of

'+&er#e,#$3$

+

Mo,$or l3er

f",!$o, $e#$

I,#$r"!$

&a$e,$ $o $a)edr"g e4a!$l+

a# &re#!r*e

Ad3#e &a$e,$

$'a$ a,$a!d#

!a, *e "#ed

('le $a),g


14/22

dr"g ",le##

o$'er(#e

dre!$ed *+

&re#!r*er

ar. $'e

&a$e,$ ,o$ $o

!'e( or !r"#$

&elle$ *e!a"#e

$'# !a,

,a!$3a$e $'e

dr"g#

NAME

OF

DRUG

MECHANIS

M OF

ACTION

CLASSIFICATI

ON

DOSAGE INDICATIO

N

CONTRAINDI

CA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


15/22

BRAND

NAME:

Cal$ra$e

11

O#-Cal

211

T".#

E4$ra

T".#

C'e(+

delg'$

GENERI

C

NAME:

Cal!".

Car*o,a

$e

Red"!e

# $o$ala!dload ,

GI$ra!$/ele3a$e#ga#$r!&H $ored"!e&e,a!$3$+/

#$re,g$'e,#ga#$r!."!o#al*arrer/ a,d,!rea#e#e#o&'a

geal#&',!$er$o,e

Cal!".

Sal$

211

.g

$a*

$'ree

$.e#

a da+

A!d

,dge#$

o,/

!al!".

#"&&le

.e,$

Co,$ra,d

!a$ed $o

&a$e,$#

($'

,!rea#ed

!al!".

le3el ,

*lood

a,d7or

,!rea#ed

!al!". ,

"r,e/

)d,e+

#$o,e/

,!rea#ed

le3el of

3$a., D/

a,d

&'o#&'a$e

, *lood

CNS:

Heada!

'e/

rr$a*l$

+/(ea),e

##

GI:

Na"#ea/

!o,#$&a

$o,/

>a$"le,

!e/

re*o",d

'+&era!

d$+

A##e## for

,a"#ea a,d

3o.$,g/

a,ore4a/$'r#$/

#e3ere

!o,#$&a$o,

A##e# for

'ear$*"r,/

,dge#$o,/

a*do.,al

&a,

Mo,$or VS

e#&e!all+ BP

a,d PR

Mo,$or

#er".

!al!".*efore

$rea$.e,$

Re!ord

a.o",$ a,d

!o,##$e,!+

of #$ool


16/22

a$!' for

e3de,!e of

'+&er)ale.a

NAME

OF

MECHANIS

M OF

CLASSIFICATI

ON

DOSAGE INDICATION CONTRAINDI

CA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


17/22

DRUG ACTION

BRAND

NAME:

Ca$a&re

#Ca$a&r

e-TTS

e,loga

GENERI

C NAME:

Clo,d,

e

U,),o(

,

T'o"g'$

$o#$."la$

e al&'a

re!er$or

a,d

,'*$

$'e

!e,$ral

3a#o.o

$or!e,$er#/

de!rea#

,g

#+.&'a

$$!

o"$>o(

$o $'e

'ear$/

)d,e+/

a,d

&er&'e

ral

3a#!"la$

"re a,d

lo(er,

g

&er&'e

Ce,$rall+

a!$,g

al&'a

ago,#$

2.!g7

$a*

o,!e a

da+

E##e,$al

a,d re,al

'+&er$e,#

o, Se3ere

!a,!er

&a, D+#.e,or

r'ea

Co,$ra,d

!a$ed $o

&a$e,$#

($'#e3ere

!oro,ar+

,#"!e

,!+/

!o,d"!$o

,

d#$"r*a,

!e/ re!e,$

MI/!ere*ro3a

#!"lar

d#ea#e/

CRF/ or

.&ared

l3er

f",!$o,

CNS:Dro(#,e

##/

d;;,e##/

#eda$o,/

(ea),e#

#/

fa$g"e/

ag$a$o,

/

de&re##

o, CV:

Brad+!ar

da/

or$'o#$a$

!

'+&o$e,#

o,

GI:

Co,#$&a

$o,/ dr+.o"$'/

a,ore4a GU:

Ur,e

re$e,$o,

/

.&o$e,!

e

O*#er3e

&a$e,$ $o

$olera,!e $'edr"g#

$'era&e"$!

e


18/22

ral

3a#!"la

r

re##$a,

!e/ BPa,d HR

Skin:

Pr"r$"#/

ra#'

I,for. &a$e,$

$'a$ d;;,e##

"&o, #$a,d,g

!a, *e.,.;ed *+

r#,g #lo(l+

fro. #$$,g or

l+,g &o#$o,

Ad3#e &a$e,$

$o a3od

#"dde,

&o#$o,

!'a,ge#

NAME

OF

MECHANIS

M OF

CLASSIFICATI

ON


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


19/22

DRUG ACTION

BRAND

NAME:

A$"r,,

GENERI

C

NAME:

A$or3a#

$a$,

HMG-

CoA

red"!$

a#e

,'*$o

r?

,'*$#

ra$e-

l.$,g

#$e& ,

!'ole#$

erol*o#+,$

'e##

*+

!o.&e

$$3el+

,'*$

,g

HMG-

CoAred"!$

a#e

HMG-

CoA

red"!$a#

e

,'*$or

91.g7

$a*

o,e

$a*

7da+

Ad",!$

$o de$ ,

&r.ar+

'+&er!'ol

e#$erole

.a

5'e$ero;+

go"#

fa.lal

a,d

,o,fa.l

al6 a,d.4ed

d+#l&de

.a

5T+&e# IIa

a,d II*6

$o red"!e

$o$al-C/

LDL-C/

a&o Ba,d TG/

a,d $o

,!rea#e

HDL-C To red"!e

r#) of MI/

Co,$ra,

d!a$ed

,

&a$e,$#

($'

#e3ere

l3er

&ro*le.

#/ ('o

are

$a),g

HIV&ro$ea#e

,'*$or

#/ d"r,g

&reg,a,

!+ a,d

*rea#$fe

ed,g/

a,d

'+&er#e,#$3$+

CNS:

Heada!

'e/

,#o.a

CV:

Per&'er

al

ede.a

GI:

A*do.

,al

&a, /

!o,#$&a

$o,/

,a"#ea

GU:

UTI RESPIR

ATORY:*ro,!'$

#

Skin:ra#'

Tea!' &a$e,$

a*o"$ &ro&er

de$ar+

.a,age.e,$

/ (eg'$

!o,$rol/ a,d

e4er!#e

ar. &a$e,$

$o a3od

al!o'ol

Tell &a$e,$ $o

,for.

&re#!r*er of

ad3er#e

rea!$o, #"!'

a# fe3er

Ad3#e&a$e,$ $'a$

dr"g !a, *e

$a)e, a$ a,+

$.e of da+/

($'o"$

regard $o

.eal#


20/22

S$ro)e

a,d

a,g,a

NAME

OF

MECHANIS

M OF

CLASSIFICA

TION


ICA-TION

ADVERS

EFFECT

NURSING

RESPONSIBILITY


21/22

DRUG ACTION

BRAND

NAME:

Le3a"

,

GENERI

C

NAME:

Le3o>o

4a!,

I,'*$#

*a!$er

al? DNA

g+ra#e

a,d

&re3e,

$ DNA

re&l!a$

o,/

$ra,#!r

&$o,/

r$e&ar/ a,d

re!o.

*,a$o

, ,

#"#!e&

$*le

*a!$er

a

Flo"ro"

,olo,e

211.

g7 $a*O,e

$a*

OD

$.e#

da+#

A!"$e

*a!$eral

#,"#$#

!a"#ed

*+

S$r&$o!o!

"#

P,e".o,

ae Co..",

$+

a!"re#&,e".o,

a fro. S

P,e".o,

ae A!"$e

&el3!

,>a..a

$or+

Mld $o.odra$e

UTI

Co,$ra,

d!a$ed

,

&a$e,$

($'

'+&er#e

,#$3$+

$o dr"g

CNS:

Se;"re/

d;;,e#

#/

'eada!'

e/

,#o.,

a CV:

C'e#$

&a,/

&al&$a$

o,# GI:

A*do.

,al &a,/

!o,#$&a

$o,/

darr'ea

/

>a$"le,!e REPIRAT

ORY:Allerg!

&,e".o

,$# SIN:

Mo,$or

gl"!o#e le3el

a,d re,al/

'e&a$! a,d

'e.a$o&oe$!

*lood #$"de#

Tell $o &a$e,$

$o $a)e dr"# a#

&re#!r*e/

e3e, f #g,#

a,d #+.&$o.#d#a&&ear

Ad3#e &a$e,$

$o $a)e dr"g

($' &le,$+ of

>"d#

ar, &a$e,$

$o a3od

'a;ardo"#

a!$3$e#

Ad3#e $'e

&a$e,$ $o

a3od

e4!e##3e

#",lg'$ a,d


22/22

P'o$o#e

,#$3o$+

/

&r"r$"#/

ra#'

(ear

&ro$e!$3e

!lo$',g ('e,

o"$ door#

I,#$r"!$ $'e

&a$e,$ $o

,o$f+

&re#!r*er of

loo#e #$ool or

darr'ea

Dialysis Drugs(tesis drugs)

Documents

Transcript of Dialysis Drugs(tesis drugs)